Search for persons
X
?
1
Table_3_Long-Term Cardiac Safety and Survival Outcomes of N..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/Table_3_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14938911. , 2021
https://figshare.com/articles/dataset/Table_3_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14938911. , 2021
?
2
Table_2_Long-Term Cardiac Safety and Survival Outcomes of N..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/Table_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14939148. , 2021
https://figshare.com/articles/dataset/Table_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14939148. , 2021
?
3
Table_1_Long-Term Cardiac Safety and Survival Outcomes of N..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/Table_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14938899. , 2021
https://figshare.com/articles/dataset/Table_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14938899. , 2021
?
4
DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes ..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/DataSheet_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14938890. , 2021
https://figshare.com/articles/dataset/DataSheet_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14938890. , 2021
?
5
Table_3_Long-Term Cardiac Safety and Survival Outcomes of N..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/Table_3_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14939151. , 2021
https://figshare.com/articles/dataset/Table_3_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14939151. , 2021
?
6
DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes ..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/DataSheet_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14939142. , 2021
https://figshare.com/articles/dataset/DataSheet_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14939142. , 2021
?
7
DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes ..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/DataSheet_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14939139. , 2021
https://figshare.com/articles/dataset/DataSheet_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14939139. , 2021
?
8
Table_1_Long-Term Cardiac Safety and Survival Outcomes of N..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/Table_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14939145. , 2021
https://figshare.com/articles/dataset/Table_1_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14939145. , 2021
?
9
DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes ..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/DataSheet_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14938893. , 2021
https://figshare.com/articles/dataset/DataSheet_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Stu/14938893. , 2021
?
10
Table_2_Long-Term Cardiac Safety and Survival Outcomes of N..:
Miguel J. Gil-Gil (3074085) ; Meritxell Bellet (58585) ; Milana Bergamino (6389735)...
https://figshare.com/articles/dataset/Table_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14938905. , 2021
https://figshare.com/articles/dataset/Table_2_Long-Term_Cardiac_Safety_and_Survival_Outcomes_of_Neoadjuvant_Pegylated_Liposomal_Doxorubicin_in_Elderly_Patients_or_Prone_to_Cardiotoxicity_and_Triple_Negative_Breast_Cancer_Final_Results_of_the_Multicentre_Phase_II_CAPRICE_Study_d/14938905. , 2021
?
11
sj-docx-1-tam-10.1177_17588359211053416 – Supplemental mate..:
Laia Garrigós (11644057) ; Cristina Saura (9572423) ; Clara Martinez-Vila (11644060)...
https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359211053416_Supplemental_material_for_COVID-19_in_breast_cancer_patients_a_subanalysis_of_the_OnCovid_registry/16926835. , 2021
https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359211053416_Supplemental_material_for_COVID-19_in_breast_cancer_patients_a_subanalysis_of_the_OnCovid_registry/16926835. , 2021
1-11